Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic evaluation of liver fibrosis to assess hepatocellular carcinoma risk in patients with chronic hepatitis B receiving nucleoside analogs treatment

Published:2024 Issue: Volume:66 Page:
ISSN:1678-9946
Container-title:Revista do Instituto de Medicina Tropical de São Paulo
language:
Short-container-title:Rev. Inst. Med. trop. S. Paulo

Author:

Luo Jia¹,Yuan Ming²,Li Shan¹,Chen Lijuan¹,Zhou Mingsha¹,Li Hailan¹,Bai Xiuyuan¹,Zhang Zhiyu¹,Zeng Weiqi¹,Sun Xueyi¹,Zhang Qiongfang¹,Chen Yi¹,Zhou Li¹^ORCID

Affiliation:

1. Chongqing Medical University, China

2. Chongqing Medical and Pharmaceutical College, China

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0036-46652024000100214&tlng=en

Reference32 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Lancet Gastroenterol Hepatol,2018

2. Hepatitis B virus infection;Trépo C;Lancet,2014

3. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer A;Lancet,2015

4. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection;Kim BK;Oncology,2011

5. Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B;Tamaki N;J Med Virol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP